Adaptive expansion of biomarker populations in phase 3 clinical trials
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),General Medicine
Reference21 articles.
1. Biomarker-guided adaptive trial designs in phase II and phase III: a methodological review;Antoniou;PLoS ONE,2017
2. Evaluation of early efficacy endpoints for proof-of-concept trials;Chen;J. Biopharm. Stat.,2013
3. A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development;Chen;Contemp. Clin. Trials,2018
4. Adaptive informational design of confirmatory phase III trials with an uncertain biomarker effect to improve the probability of success;Chen;Stat. Biopharm. Res.,2016
5. Hypothesis testing in a confirmatory phase III trial with a possible subset effect;Chen;Stat. Biopharm. Res.,2009
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Improving Collection and Analysis of Overall Survival Data;Clinical Cancer Research;2024-07-17
2. Conditional bias adjusted estimator of treatment effect in 2-in-1 adaptive design;Journal of Biopharmaceutical Statistics;2024-06-06
3. A promising biomarker adaptive Phase 2/3 design – Explained and expanded;Contemporary Clinical Trials Communications;2023-12
4. Application of Group Sequential Methods to the 2-in-1 Design and Its Extensions for Interim Monitoring;Statistics in Biopharmaceutical Research;2023-04-18
5. Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small Patients;Pediatric Drugs;2022-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3